Submission Details
| 510(k) Number | K231253 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 01, 2023 |
| Decision Date | July 07, 2023 |
| Days to Decision | 67 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K231253 is an FDA 510(k) clearance for the Overture Orthopaedics Patellofemoral System, a Prosthesis, Knee, Patello/femoral, Semi-constrained, Cemented, Metal/polymer (Class II — Special Controls, product code KRR), submitted by Overture Resurfacing, Inc. (New York, US). The FDA issued a Cleared decision on July 7, 2023, 67 days after receiving the submission on May 1, 2023. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3540.
| 510(k) Number | K231253 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 01, 2023 |
| Decision Date | July 07, 2023 |
| Days to Decision | 67 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | KRR — Prosthesis, Knee, Patello/femoral, Semi-constrained, Cemented, Metal/polymer |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3540 |